XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $240K invested in XTL Biopharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$200 |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$41.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $199K | – | – | – |
|
|
2
Morgan Stanley
New York
| $41.2K | -$600 | -600 | -1% |
|
|
3
BNP Paribas Financial Markets
Paris,
France
| $200 | +$200 | +200 | New |
|